Ausupreme International Holdings Limited 澳至尊國際控股有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） (Stock Code 股份代號: 2031) N OT IF IC ATI O N LET T E R 通 知 信 函 24 December 2024 澳至尊國際控股有限公司(「本公司」) – 2024/2025 中期報告（「本次公司通訊文件 本次公司通訊文件 本次公司通訊文件」）之發佈通知 本公司的本次公司通訊文件的中、英文版本已上載於本公司網站 www.ausupreme.com 及香港交易及結算所有限公司網站（「香港交易所網站」） www.hkexnews.hk（「網站版本」），本公司強烈建議 閣下閱覽本公司本次及日後公司通訊（ 附 註 1）的網站版本。 Dear Registered Shareholder, Ausupreme International Holdings Limited (the "Company") – Notice o ...

Ausupreme International Holdings Limited 澳至尊國際控股有限公司 (Incorporated in the Cayman Islands with limited liability) （於開曼群島註冊成立的有限公司） (Stock Code 股份代號: 2031) N OT IF IC ATI O N LET T E R 通 知 信 函 Dear Non-registered Shareholder(Note 1) , Ausupreme International Holdings Limited (the "Company") – Notice of Publication of 2024/2025 Interim Report (the "Current Corporate Communication(s)") The English and Chinese versions of the Company's Current Corporate Communication(s) are available on the Company's website at ...

Financial Performance - Revenue increased by 15% year-over-year, driven by strong sales in the Asia-Pacific region [1]. - Net profit margin improved to 12%, up from 10% in the previous quarter [2]. - Operating expenses rose by 8%, primarily due to increased marketing and R&D investments [3]. Market Expansion - The company successfully entered two new markets in Europe, contributing to a 20% increase in international sales [4]. - A new distribution center was opened in South America to support regional growth [5]. - Strategic partnerships were formed with local retailers to enhance market penetration [6]. Product Development - Launched three new products in the tech segment, which accounted for 25% of total revenue [7]. - R&D spending increased by 10% to accelerate innovation and product differentiation [8]. - Customer feedback on the new product line has been overwhelmingly positive [9]. Operational Efficiency - Implemented a new ERP system, reducing operational costs by 5% [10]. - Streamlined supply chain processes, resulting in a 15% reduction in delivery times [11]. - Employee training programs were expanded to improve productivity and reduce turnover [12]. Sustainability Initiatives - Achieved a 30% reduction in carbon emissions through the adoption of renewable energy sources [13]. - Launched a recycling program that has successfully diverted 50% of waste from landfills [14]. - Committed to achieving net-zero emissions by 2030, with interim targets set for 2025 [15]. Corporate Governance - Appointed two new independent directors to the board, enhancing oversight and strategic guidance [16]. - Strengthened compliance programs to ensure adherence to global regulatory standards [17]. - Conducted a comprehensive review of corporate policies to improve transparency and accountability [18].

Financial Performance - Revenue for the six months ended September 30, 2024, was HKD 126,540,000, a decrease of 3.5% from HKD 130,783,000 in the same period of 2023[3] - Gross profit for the same period was HKD 110,347,000, down from HKD 113,675,000, reflecting a decline of 2.9%[3] - Profit before tax decreased to HKD 15,939,000, a decline of 17.0% compared to HKD 19,258,000 in 2023[5] - Net profit for the period was HKD 13,239,000, down 12.8% from HKD 15,173,000 in the previous year[5] - Total comprehensive income for the period was HKD 14,685,000, slightly up from HKD 14,356,000 in 2023, indicating a growth of 2.3%[5] - The company reported a basic earnings per share of HKD 1.74, down from HKD 1.99 in the previous year, reflecting a decrease of 12.6%[5] - The profit attributable to the company's owners for the six months ended September 30, 2024, was HKD 13,239,000, compared to HKD 15,173,000 for the same period in 2023, representing a decrease of approximately 12.8%[41] - Basic earnings per share for the six months ended September 30, 2024, were HKD 0.0174, down from HKD 0.0199 in the previous year[67] Revenue Breakdown - Revenue from health supplements was HKD 120,398,000, down 3.4% from HKD 125,092,000 year-on-year[21] - Revenue from personal care products increased to HKD 5,766,000, up 11.6% from HKD 5,167,000 in the previous year[21] - Revenue from health supplement products decreased by 3.8% to HKD 120,398,000, while personal care products increased by 11.6% to HKD 5,766,000[62] - The company's gross profit margin slightly increased by 0.3% to 87.2% for the six months ended September 30, 2024[65] Expenses and Costs - Total sales and distribution expenses increased by 2.9% to HKD 78,460,000, primarily due to rising employee costs[65] - The cost of inventory recognized as an expense was HKD 16,193,000, down from HKD 17,108,000 in the previous year, reflecting a reduction of approximately 5.3%[40] - Total depreciation for the period was HKD 7,584,000, slightly down from HKD 7,660,000 in the previous year, indicating a decrease of about 1%[40] - Advertising and promotional expenses included in sales and distribution expenses were HKD 3,905,000, up from HKD 3,262,000 in the previous year, reflecting an increase of approximately 19.7%[40] Assets and Liabilities - Cash and cash equivalents increased to HKD 80,030,000 from HKD 69,844,000, representing a growth of 14.0%[7] - Inventory rose to HKD 25,153,000, an increase of 15.5% from HKD 21,787,000 as of March 31, 2024[7] - Total assets decreased to HKD 183,621,000 from HKD 187,184,000, a decline of 1.9%[9] - Non-current assets totaled HKD 87,830,000, a slight decrease from HKD 89,665,000 as of March 31, 2024[7] - The total outstanding bank borrowings amounted to HKD 2,275,000 as of September 30, 2024, down from HKD 2,486,000 as of March 31, 2024[70] - The company's lease liabilities payable to Tiger amounted to HKD 1,408,000 as of September 30, 2024, down from HKD 1,802,000 as of March 31, 2024[56] - The debt-to-equity ratio was only 1.3% as of September 30, 2024, compared to 1.4% as of March 31, 2024, indicating a reasonable level of capital leverage[70] Tax and Other Income - The company reported a total tax expense of HKD 2,700,000 for the period, compared to HKD 4,085,000 in the previous year, indicating a decrease of 33.8%[33] - The company recognized a loss of HKD 224,000 from other gains and losses, a significant improvement from a loss of HKD 1,651,000 in the same period last year[28] - The company's other income increased by 72.0% to HKD 1,087,000, mainly due to increased bank interest income from rising interest rates[65] - Bank interest income rose to HKD 891,000, a significant increase of 92.1% compared to HKD 464,000 in the prior period[26] Operational Highlights - The company has only one operating segment, which is the retail and wholesale of health and personal care products[25] - The company operated 18 specialty stores and 67 consignment counters as of September 30, 2024, compared to 18 specialty stores and 63 consignment counters as of March 31, 2024[59] - The average credit period for trade customers and consignees is between 0 to 60 days, with accounts receivable as of September 30, 2024, totaling HKD 21,624,000, up from HKD 21,163,000 as of March 31, 2024[46][47] - The total accounts payable as of September 30, 2024, was HKD 15,328,000, compared to HKD 13,712,000 as of March 31, 2024, indicating an increase of approximately 11.8%[51] Future Outlook and Strategic Plans - The company anticipates that global interest rates will gradually decrease to support economic development, with geopolitical tensions impacting the market[79] - The group plans to enhance its product portfolio to cater to changing customer preferences and will continue to optimize its online and offline store networks[79] - The company has not made any significant investments, acquisitions, or disposals in subsidiaries or joint ventures during the six months ended September 30, 2024[74] Governance and Shareholder Relations - The board has decided not to declare an interim dividend for the six months ended September 30, 2024, consistent with the previous year[38] - The board expresses gratitude to shareholders, business partners, and customers for their ongoing support[91] - The board consists of two executive directors and three independent non-executive directors[92] - The report emphasizes that in case of discrepancies, the English version prevails[93] Market Conditions - The overall retail sales value in Hong Kong decreased by approximately 10.8% during the same period, reflecting the challenging market conditions[58] - As of September 30, 2024, the group's current assets net value was HKD 95,791,000, down from HKD 97,519,000 as of March 31, 2024[69] - The current ratio as of September 30, 2024, was approximately 2.9, a decrease from 4.1 as of March 31, 2024[70] - The number of employees increased to 232 as of September 30, 2024, from 210 as of March 31, 2024[76] - There are no significant contingent liabilities as of September 30, 2024[75]

Ausupreme International Holdings Limited 澳至尊國際控股有限公司 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 代表 澳至尊國際控股有限公司 主席、執行董事及聯席行政總裁 蔡志輝 香港，二零二四年十一月十八日 （於開曼群島註冊成立的有限公司） （股份代號：2031） 董事會會議日期 澳至尊國際控股有限公司（「本公司」）宣佈，本公司謹訂於二零二四年十一月二十八 日（星期四）舉行本公司董事會（「董事會」）會議，藉以（其中包括）考慮及批准本公司 及其附屬公司截至二零二四年九月三十日止六個月之未經審核綜合財務業績以供發 佈及考慮宣派中期股息（如有）。 於本公告日期，董事會包括兩名執行董事，即蔡志輝先生（主席兼聯席行政總裁）及 何家敏女士（副主席兼聯席行政總裁）；以及三名獨立非執行董事，即陸定光教授、 尹祖伊博士及彭倩薇女士。 ...

Financial Performance - The company reported a revenue of HKD 269,022,000 and a profit of HKD 30,674,000 for the fiscal year, marking significant growth compared to 2023[17]. - The board proposed a final cash dividend of HKD 0.02 per share to reward shareholders for their support[17]. Sales and Marketing Strategies - The company is focusing on optimizing sales and marketing strategies to adapt to changing consumer behaviors and rising operational costs[18]. - The company plans to enhance its online and offline sales networks through detailed analysis and advanced technology[25]. - The company is focused on precise market demand capture and channel marketing characteristics as part of its e-commerce strategy and development plan[42]. - The company has deepened collaborations with major e-commerce platforms, including HKTVmall and Tmall, significantly increasing market penetration[82]. - The company has established an e-commerce operation team in Shenzhen and Hainan to tailor its services based on data-driven insights[65]. - The company has deepened partnerships with major e-commerce platforms, including HKTVmall, Tmall, and JD.com, significantly increasing brand penetration in the market[99]. - The company has a strong focus on data-driven decision-making, utilizing market insights to refine its marketing strategies and product development[99]. Product Development and Innovation - The company emphasizes the development of new high-quality products to meet evolving customer preferences[25]. - The company is focused on developing new products and technologies to meet evolving consumer needs and enhance its competitive edge[42]. - The company continues to innovate its product offerings, catering to the preferences of consumers in the Asia-Pacific region[75]. - The company has expanded its product offerings, continuously innovating to meet the preferences of consumers in the Asia-Pacific region[99]. Corporate Social Responsibility - The company is committed to corporate social responsibility, supporting various sports activities and promoting a healthy lifestyle among employees and the community[30]. - The company is actively participating in community volunteer activities to support the healthy growth and development of children[9]. - The company emphasizes a culture of health and wellness, organizing various physical activities for employees and sponsoring community sports projects[88]. - The company actively supports youth development and community sports, participating in multiple marathons and athletic events to encourage a healthy lifestyle[102][120]. - The company is committed to drug prevention initiatives, engaging with local communities to promote healthy lifestyles among youth[129]. - The company emphasizes a caring corporate culture, viewing employees as its most valuable asset and promoting community engagement through various initiatives[151]. - The company is dedicated to fostering a harmonious corporate culture, encouraging employees to participate in volunteer activities and community service[138]. Awards and Recognition - The company has received multiple awards, including the Outstanding Listed Company Award and the Hong Kong Brand 10-Year Achievement Award[21]. - The company has been recognized for 19 consecutive years by the Hong Kong Tourism Board for quality service, indicating strong brand reputation and customer trust[38]. - The company has received multiple awards, including the Hong Kong Brand Ten-Year Achievement Award and the Asia Excellence Brand Award, reflecting its strong market position[33]. - The company has achieved significant recognition, receiving numerous awards that enhance its brand motivation and commitment to customer health and beauty[141]. - The company received multiple awards, including the Most Popular Health Brand Award and the Most Loved Maternal and Infant Supplement Brand[157]. - The company has been recognized as an outstanding enterprise in the Greater Bay Area and has received accolades for employee care[157]. - In 2023, the company received the "Corporate Together Move" award from the Hong Kong Sports Fund, recognizing its efforts in promoting a healthy and active work environment for employees[145]. Corporate Governance and Compliance - The company is committed to maintaining a high level of compliance and ethical standards in its operations, which is crucial for building trust with stakeholders[39]. - The company aims to maintain effective corporate governance to ensure accountability within its management structure[180]. - The company has adopted the "Standard Code" as its code of conduct for securities trading by directors, confirming compliance throughout the year[197]. - The management team is committed to sustainable growth through prudent and flexible responses to market conditions[168]. Market Expansion and Operations - The company has established subsidiaries in mainland China, Macau, and Singapore, indicating a strategy for market expansion[44]. - As of March 31, 2024, the company operates 18 specialty stores and 63 consignment counters in Hong Kong, Macau, and Singapore, with a cross-border e-commerce experience store opened in Shenzhen[44]. - As of March 31, 2024, the company operates 18 specialty stores and 63 consignment counters in Hong Kong, Macau, and Singapore, with expansion into Shenzhen[63]. - The company aims to enhance long-term value for stakeholders through innovative thinking and resilient efforts in business development[37]. - The management team has extensive experience in finance, marketing, and technology, contributing to the company's strategic direction[173][174][176]. - The chairman has been awarded multiple honors, including the World Outstanding Young Chinese Entrepreneur Award[163]. - The company is actively pursuing strategies for mergers and acquisitions to strengthen its market presence and operational capabilities[44].

[Financial Highlights](index=1&type=section&id=Financial%20Highlights) The Group's performance rebounded strongly, with total revenue surging 84.1% to HK$269.02 million and profit for the year soaring to HK$30.67 million, driven by Hong Kong's tourism recovery and improved gross margin Key Financial Indicators for FY2024 | Indicator | 2024 FY | 2023 FY | YoY Change | | :--- | :--- | :--- | :--- | | Revenue (HK$ Thousand) | 269,022 | 146,158 | +84.1% | | Gross Profit (HK$ Thousand) | 234,293 | 121,234 | +93.2% | | Profit for the Year (HK$ Thousand) | 30,674 | 497 | +6071.8% | | Gross Margin (%) | 87.1% | 82.9% | +4.2 percentage points | | Basic Earnings Per Share (HK Cents) | 4.03 | 0.07 | +5657.1% | | Proposed Final Dividend (HK Cents/share) | 2.0 | 1.0 | +100% | - Significant performance growth was primarily attributed to the recovery of inbound tourism and consumer sentiment after the lifting of pandemic-related restrictions, alongside effective sales and marketing resource allocation[89](index=89&type=chunk)[91](index=91&type=chunk) [Consolidated Financial Statements](index=1&type=section&id=Consolidated%20Financial%20Statements) This section presents the Group's detailed financial statements as of March 31, 2024, including the consolidated statement of profit or loss and other comprehensive income and the consolidated statement of financial position, reflecting the company's operating results and financial position [Consolidated Statement of Profit or Loss and Other Comprehensive Income](index=1&type=section&id=Consolidated%20Statement%20of%20Profit%20or%20Loss%20and%20Other%20Comprehensive%20Income) For the year ended March 31, 2024, the Group's revenue was HK$269.02 million, an 84.1% increase year-on-year, with profit before tax reaching HK$37.52 million and profit for the year at HK$30.67 million Consolidated Statement of Profit or Loss Summary (HK$ Thousand) | Item | 2024 | 2023 | | :--- | :--- | :--- | | Revenue | 269,022 | 146,158 | | Cost of Sales | (34,729) | (24,924) | | **Gross Profit** | **234,293** | **121,234** | | Selling and Distribution Expenses | (159,450) | (90,837) | | General and Administrative Expenses | (35,490) | (32,421) | | **Profit Before Tax** | **37,519** | **1,160** | | Income Tax Expense | (6,845) | (663) | | **Profit for the Year** | **30,674** | **497** | [Consolidated Statement of Financial Position](index=3&type=section&id=Consolidated%20Statement%20of%20Financial%20Position) As of March 31, 2024, the Group's total assets were HK$218.81 million, total liabilities HK$40.60 million, and net assets increased to HK$178.21 million, demonstrating robust liquidity with net current assets of HK$97.52 million Consolidated Statement of Financial Position Summary (HK$ Thousand) | Item | March 31, 2024 | March 31, 2023 | | :--- | :--- | :--- | | **Non-current Assets** | **89,665** | **93,405** | | **Current Assets** | **129,146** | **96,007** | | Of which: Cash and Cash Equivalents | 69,844 | 41,044 | | **Total Assets** | **218,811** | **189,412** | | **Current Liabilities** | **31,627** | **26,138** | | **Non-current Liabilities** | **8,974** | **7,214** | | **Total Liabilities** | **40,601** | **33,352** | | **Net Assets** | **178,210** | **156,060** | [Notes to the Consolidated Financial Statements](index=5&type=section&id=Notes%20to%20the%20Consolidated%20Financial%20Statements) This section details the basis of financial statement preparation, application of new accounting standards, and provides in-depth analysis and disclosure of key items such as revenue, segments, taxation, earnings per share, and dividends, with the core business being retail and wholesale of health and personal care products as a single reportable segment [Changes in Accounting Policies](index=5&type=section&id=2.%20Application%20of%20new%20and%20revised%20HKFRS) This year, the Group adopted several new and revised HKFRSs, including retrospective adjustments for the abolition of the MPF offsetting mechanism, which had no material impact on prior period financial positions, with other revisions primarily affecting disclosure methods - The Group has adopted several new and revised Hong Kong Financial Reporting Standards for the first time, including definitions of accounting estimates and deferred tax related to a single transaction[15](index=15&type=chunk)[36](index=36&type=chunk) - In response to the abolition of the MPF offsetting mechanism in Hong Kong, the Group retrospectively implemented HKICPA guidance, changing the accounting treatment for long service payment obligations, resulting in a slight increase in general and administrative expenses and finance costs[41](index=41&type=chunk)[42](index=42&type=chunk)[44](index=44&type=chunk) [Revenue and Segment Reporting](index=10&type=section&id=4.%20Revenue%20and%20segment%20reporting) All Group revenue is derived from retail and wholesale of health and personal care products, forming a single reportable segment, with health supplements accounting for 95.5% of total revenue and consignment counters being the primary channel, growing 138.4% to 70.7% of sales - The Group has only one reportable and operating segment, which is the retail and wholesale of health and personal care products[28](index=28&type=chunk)[71](index=71&type=chunk) Revenue by Product Category (HK$ Thousand) | Product Category | 2024 | 2023 | YoY Change | | :--- | :--- | :--- | :--- | | Health Supplement Products | 256,941 | 141,400 | +81.7% | | Personal Care Products | 11,092 | 3,075 | +260.7% | | Honey and Pollen Products | 989 | 1,683 | -41.2% | | **Total** | **269,022** | **146,158** | **+84.1%** | Revenue by Sales Channel (HK$ Thousand) | Sales Channel | 2024 | 2023 | YoY Change | | :--- | :--- | :--- | :--- | | Specialty Stores | 43,546 | 39,890 | +9.2% | | Consignment Counters | 190,305 | 79,829 | +138.4% | | E-commerce | 20,583 | 17,921 | +14.9% | | Other Sales Channels | 14,588 | 8,518 | +71.3% | | **Total** | **269,022** | **146,158** | **+84.1%** | [Dividends](index=15&type=section&id=10.%20Dividends) The Board recommends a final dividend of HK$0.02 per ordinary share for the year ended March 31, 2024, totaling approximately HK$15.24 million, doubling last year's dividend, pending AGM approval - The Board recommended a final dividend of **HK$0.02 per share**, totaling **HK$15.24 million**, for the year ended March 31, 2024[107](index=107&type=chunk)[130](index=130&type=chunk) - The final dividend for 2023 was **HK$0.01 per share**, totaling **HK$7.62 million**[60](index=60&type=chunk)[107](index=107&type=chunk) [Management Discussion and Analysis](index=18&type=section&id=Management%20Discussion%20and%20Analysis) Management reviewed the operating environment and performance, noting significant revenue and profit growth driven by Hong Kong's tourism recovery, maintaining a robust financial position with ample liquidity and low gearing, and plans to enrich product portfolios, optimize OMO sales, and leverage AI for sustainable growth [Market Overview and Business Review](index=18&type=section&id=Market%20Overview%20and%20Business%20Review) Visitor arrivals in Hong Kong surged following the lifting of pandemic restrictions and promotional campaigns, stimulating the retail market, leading to the Group's revenue growing 84.1% to HK$269.02 million and profit reaching HK$30.67 million, though challenges like cross-border consumption trends persist - Total visitor arrivals in Hong Kong continuously increased by **715.0%** to approximately **40.81 million**, stimulating retail activity[113](index=113&type=chunk) - Group revenue increased by **84.1%**, primarily due to the recovery of Hong Kong's tourism industry, boosting tourist spending[89](index=89&type=chunk) - Management noted market challenges including macroeconomic uncertainties, increased cost pressures, and changes in local consumer behavior due to Hong Kong residents' cross-border consumption[66](index=66&type=chunk) [Financial Review](index=19&type=section&id=Financial%20Review) This year, cost of sales increased 39.3% with revenue, but gross margin improved to 87.1% due to optimized pricing; sales and distribution expenses rose 75.5% from higher consignment fees, and other income significantly decreased due to the absence of government subsidies, resulting in an annual profit of HK$30.67 million - Gross margin increased from **82.9% to 87.1%**, primarily due to optimized pricing policies based on market conditions[92](index=92&type=chunk) - Sales and distribution expenses increased by **75.5%**, mainly due to a **166.8%** rise in consignment expenses related to revenue growth[119](index=119&type=chunk) - Other income decreased by **71.8%**, primarily due to the non-recognition of government subsidies and landlord rental concessions in the current year[118](index=118&type=chunk) [Liquidity and Financial Resources](index=21&type=section&id=Liquidity%20and%20Financial%20Resources) The Group's financial position is robust, with total cash and time deposits of HK$75.36 million and a current ratio of 4.1 as of March 31, 2024, and a very low debt-to-equity ratio of 1.4%, while foreign exchange risks from JPY, AUD, and RMB are monitored without a hedging policy Liquidity and Capital Structure | Indicator | March 31, 2024 (HK$ Thousand) | March 31, 2023 (HK$ Thousand) | | :--- | :--- | :--- | | Net Current Assets | 97,519 | 69,869 | | Net Assets | 178,210 | 156,060 | | Current Ratio | 4.1 | 3.7 | | Debt-to-Equity Ratio | 1.4% | 1.9% | - The Group's foreign exchange risk primarily stems from sales and purchases denominated in **JPY, AUD, and RMB**, with no hedging policy currently in place, but regular monitoring is conducted[98](index=98&type=chunk) [Future Outlook and Prospects](index=23&type=section&id=Future%20Outlook%20and%20Prospects) Facing macroeconomic uncertainties, the Group is committed to long-term development by enriching its product portfolio through R&D innovation, optimizing its OMO sales network, and leveraging AI for customer analysis to enhance personalized shopping experiences and achieve sustainable growth - The Group will continue to enrich its product portfolio and focus on **R&D innovation** to maintain customer loyalty[104](index=104&type=chunk) - Plans include utilizing advanced technologies like **Artificial Intelligence (AI)** for customer preference analysis to support an **Online-Merge-Offline (OMO)** sales strategy, providing a unified shopping experience[132](index=132&type=chunk) - Will continuously optimize online and offline sales networks, including establishing physical stores in high-traffic areas and collaborating with reputable online platforms to deepen market penetration[146](index=146&type=chunk) [Corporate Governance and Other Information](index=24&type=section&id=Corporate%20Governance%20and%20Other%20Information) During the year, the company largely complied with the Corporate Governance Code, with a deviation regarding the Chairman and CEO roles being held by the same individual, for which the Board provided a reasonable explanation, and the annual results were reviewed by the Audit Committee and agreed upon by the auditors - The company deviated from the Corporate Governance Code's requirement for separation of Chairman and CEO roles; the Board believes the current Chairman, Mr. Choi Chi Fai, also serving as Co-CEO, is in the Group's best interest due to his industry knowledge and network, with sufficient safeguards for Board power balance[135](index=135&type=chunk)[149](index=149&type=chunk) - The Group's results for the year ended March 31, 2024, were reviewed by the Board's Audit Committee[138](index=138&type=chunk) - During the year, neither the company nor any of its subsidiaries purchased, sold, or redeemed its listed securities[134](index=134&type=chunk)

Financial Performance - Revenue for the six months ended September 30, 2023, was HKD 130,783,000, representing a 113.4% increase compared to HKD 61,292,000 in the same period of 2022[4] - Gross profit for the same period was HKD 113,675,000, up from HKD 51,117,000, indicating a significant improvement in profitability[4] - The company reported a profit before tax of HKD 19,258,000, compared to a loss of HKD 433,000 in the previous year[4] - Net profit for the period was HKD 15,173,000, a turnaround from a loss of HKD 365,000 in the prior year[4] - Basic earnings per share for the period was HKD 1.99, compared to a loss per share of HKD 0.05 in the same period last year[6] - The group reported a profit attributable to owners of the company of HKD 15,173,000 for the six months ended September 30, 2023, compared to a loss of HKD 365,000 in the same period of 2022[49] - The group recorded a profit of HKD 15,173,000 for the period, a significant turnaround from a loss of HKD 365,000 in the previous year[65] Revenue Breakdown - Revenue from health supplement products reached HKD 125,092,000, a substantial increase of 111% from HKD 59,267,000 in the previous year[28] - Revenue from health supplement products rose by 111.1% to HKD 125,092,000, while personal care products increased by 307.5% to HKD 5,167,000; however, honey and pollen products decreased by 30.8% to HKD 524,000[70] - Sales from specialty stores increased by 11.4% to HKD 22,273,000, and revenue from consignment counters surged by 208.1% to HKD 94,952,000; e-commerce revenue slightly decreased by 2.5% to HKD 7,758,000[73] Assets and Liabilities - Total assets as of September 30, 2023, were HKD 172,160,000, an increase from HKD 163,274,000 as of March 31, 2023[8] - Current assets increased to HKD 119,400,000 from HKD 96,007,000, reflecting improved liquidity[8] - The total equity increased to HKD 162,796,000 from HKD 156,060,000, showing growth in shareholder value[10] - Accounts receivable increased to HKD 24,281,000 as of September 30, 2023, from HKD 16,772,000 as of March 31, 2023[53] - The group’s accounts payable rose to HKD 15,460,000 as of September 30, 2023, compared to HKD 12,202,000 as of March 31, 2023[56] - The total outstanding bank borrowings amounted to HKD 2,694,000 as of September 30, 2023, down from HKD 2,898,000 as of March 31, 2023[82] - The debt-to-equity ratio was 1.7% as of September 30, 2023, indicating a reasonable level of capital leverage[82] Cash Flow - Cash generated from operating activities was HKD 20,106,000, a recovery from a cash outflow of HKD 1,640,000 in the same period last year[17] - The company’s cash and cash equivalents rose to HKD 48,547,000 from HKD 41,044,000, indicating a stronger cash position[8] - The company’s cash and cash equivalents increased to HKD 48,547,000 from HKD 38,794,000 year-over-year, reflecting a positive cash flow trend[19] - The group incurred a net loss of HKD 1,651,000 from other losses for the six months ended September 30, 2023, compared to a loss of HKD 1,226,000 in 2022[38] - The company reported a net cash outflow from investing activities of HKD 5,602,000, compared to HKD 8,043,000 in the previous year, suggesting a reduction in capital expenditures[17] - The company’s financing activities resulted in a net cash outflow of HKD 6,747,000, slightly improved from HKD 7,305,000 in the previous year, indicating better management of financing costs[19] Market and Growth Strategy - The company plans to continue expanding its market presence and investing in new product development to sustain growth[4] - The company plans to continue expanding its product offerings in health and personal care, focusing on brand development and distribution[21] - The group plans to continue carefully selecting suitable locations for specialty stores and other sales channels to enhance brand visibility among target customers[65] - The company aims to diversify its product portfolio and optimize pricing strategies to enhance operational performance[91] - The group plans to expand its online and offline sales network to capture market share in a high financing cost environment[91] Operational Highlights - The company experienced a significant increase in sales through consignment counters, which rose to HKD 94,952,000 from HKD 30,823,000, highlighting a successful sales strategy[28] - The number of stores increased to 18 and consignment counters to 60 as of September 30, 2023, compared to 17 stores and 60 counters as of March 31, 2023[65] - The employee count increased to 201 as of September 30, 2023, up from 189 on March 31, 2023[88] Governance and Compliance - The company has adhered to the corporate governance code, with a noted exception regarding the dual role of the chairman and CEO[105] - The audit committee has reviewed and supervised the group's financial reporting system and internal control procedures during the reporting period[109] - The company has adopted a standard code for directors' securities trading, with all directors confirming compliance throughout the reporting period[107] - The company plans to appoint new independent non-executive directors within three months to comply with listing rules following the recent vacancy[106] Dividends and Shareholder Information - The group did not declare an interim dividend for the six months ended September 30, 2023, consistent with the previous year[47] - The company expressed gratitude to shareholders, business partners, and employees for their ongoing support and contributions[111] - As of September 30, 2023, Beatitudes International Ltd. held approximately 55.82% of the company's shares[96] Economic Environment - The group experienced a significant rebound in business performance due to the return of mainland Chinese tourists, despite facing economic uncertainties in Hong Kong[91] - The overall retail sales in Hong Kong increased by 16.0% from April to September 2023 compared to the same period last year, driven by the recovery of tourism[64] - The number of visitors to Hong Kong surged to approximately 18,907,000 from about 238,000 in the same period last year, significantly boosting retail activity[64]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Ausupreme International Holdings Limited 澳 至 尊 國 際 控 股 有 限 公 司 （於開曼群島註冊成立的有限公司） （股份代號：2031） 截至2023年9月30日止六個月 未經審核中期業績公告 業績 澳至尊國際控股有限公司（「本公司」）之董事（「董事」）會（「董事會」）提呈本公司及其附屬 公司（統稱「本集團」）截至2023年9月30日止六個月（「本期間」）之未經審核簡明綜合業績， 連同有關之比較數字如下： 簡明綜合損益及其他全面收益表 截至2023年9月30日止六個月 截至9月30日止六個月 2023年 2022年 附註 千港元 千港元 （未經審核） （未經審核） ...

Company Overview - The company specializes in high-quality health supplements and personal care products, certified by multiple international standards, including TGA and GMP[12]. - The company has received recognition as a "Hong Kong Excellent Brand" and has been acknowledged as a quality merchant by the Hong Kong Tourism Board for 15 consecutive years[12]. - The business has shown steady growth, supported by strong market acceptance in Hong Kong and across Asia[12]. Market Presence and Sales Strategy - As of March 31, 2023, the company operates 17 specialty stores and 60 consignment counters in Hong Kong, Macau, and Singapore, establishing a solid foundation in the region[19]. - The company has expanded its online sales strategy, enhancing its official website and custom app to improve customer experience and loyalty[15]. - The company has partnered with various e-commerce platforms, including HKTVmall and Tmall, significantly increasing market penetration[16]. - The introduction of the "Omnichat" promotional software has improved customer interaction and communication, allowing for precise promotional targeting[15]. - The company has established a cross-border e-commerce experience store in Shenzhen, further enhancing its market presence[19]. Social Responsibility and Community Engagement - The company is committed to social responsibility, actively participating in community initiatives and promoting healthy lifestyles[26]. - The company actively promotes sports activities among employees and their families, contributing to work-life balance[34]. - The company has established a karate dojo to promote the sport and has achieved notable results in local competitions, including championships in various categories[34]. - The company emphasizes social responsibility and has been involved in various charitable activities, including donations to support underprivileged students[41]. - The company supports anti-drug initiatives and has participated in events to educate youth about drug prevention[36]. - The company has organized various employee engagement activities, such as movie screenings and concerts, to foster a positive workplace culture[42]. - The company has been involved in community sports projects to encourage healthy lifestyles and support local sports development[38]. - The company has provided financial assistance to economically disadvantaged students and participated in educational seminars[51]. - The company’s chairman has been actively involved in community service and youth education initiatives, sharing experiences and insights[41]. - The company has sponsored local karate competitions and supported the Hong Kong Karate Association in organizing events[34]. - The company has a commitment to nurturing future leaders through educational support and community engagement[41]. Financial Performance - The company reported a revenue increase of 13.5% to HKD 146,158,000 for the fiscal year ending March 31, 2023, compared to the previous year[103]. - The company achieved a consolidated profit of HKD 497,000, recovering from a loss of HKD 843,000 in the previous year[103]. - The board proposed a final cash dividend of HKD 0.01 per share to reward shareholders for their support[103]. - Revenue from health supplement products increased by 15.3% to HKD 141,400,000, while personal care products and honey/pollen products saw declines of 26.3% and 10.4%, respectively[117]. - Sales through specialty stores and consignment counters increased by 7.8% to HKD 39,890,000 and 27.0% to HKD 79,829,000, respectively, driven by the influx of travelers from mainland China[119]. - The group's gross profit margin slightly improved to 82.9% from 81.7% in the previous year, despite a 5.7% increase in cost of sales to HKD 24,924,000[120]. - Other income rose by 107.9% to HKD 4,238,000, primarily due to increased government subsidies and bank interest income[120]. - The income tax expense for the year was HKD 663,000, a shift from an income tax credit of HKD 2,123,000 in the previous year, reflecting the transition from a loss to a profit[124]. Future Outlook and Strategic Initiatives - The company plans to launch new diversified products to meet the varying needs of target customers[105]. - Strategic partnerships have been established with suppliers and businesses to expand both online and physical sales networks[105]. - The company aims to recruit and build a dynamic team in various regions to support its diversified business development[105]. - The group plans to expand its product portfolio to cater to changing customer preferences and enhance customer health[138]. - The integration of online and offline sales remains a key focus, aiming to improve customer experience and loyalty[140]. - The group will continue to streamline inventory levels and optimize its physical store network to enhance operational efficiency[138]. - The company is expanding its market presence in Southeast Asia, aiming to increase market share by 30% in the region over the next two years[154]. - A strategic acquisition of a local health food brand is in progress, which is anticipated to enhance the product portfolio and increase market penetration[154]. - Investment in technology development is set at HKD 50 million, aimed at improving online sales channels and customer engagement platforms[154]. - The company plans to enhance its marketing strategies, allocating 10% of revenue towards digital marketing initiatives to boost brand visibility[154]. - The management team has emphasized a commitment to sustainability, with plans to reduce carbon emissions by 15% over the next three years[154]. Governance and Corporate Structure - The company has a strong governance structure with over 40% of the board members being independent non-executive directors[170]. - The board consists of seven members, including the chairman and co-CEOs, ensuring a balance of executive and independent oversight[170]. - The company has adopted a standard code for securities trading by directors, confirming compliance throughout the year[165]. - The management team is led by a finance director with over 20 years of experience in accounting services[160]. - The company emphasizes accountability and risk management as part of its corporate governance practices[163]. - The independent non-executive directors contribute significant business and financial expertise to the board[171]. - The company has appropriate insurance coverage for potential legal claims against directors[173]. - The finance team is responsible for overseeing corporate financing, treasury, financial reporting, and tax matters[157]. - The company has established various board committees to delegate responsibilities effectively[166]. - The management is tasked with executing the business plans and strategies adopted by the board[166]. - The board held 4 meetings during the year, including the approval of the audited consolidated financial statements for the year ended March 31, 2022, and the unaudited consolidated financial statements for the six months ended September 30, 2022[175]. - All directors attended 100% of the board meetings, with each director present for all 4 meetings[178]. - The audit committee held 3 meetings during the year, including the review and approval of the audited consolidated financial statements for the year ended March 31, 2022[185]. - The audit committee consists of three independent non-executive directors, ensuring compliance with corporate governance codes and listing rules[181]. - The remuneration committee was established on July 20, 2016, and includes two independent non-executive directors and one executive director[187]. - The company encourages all directors to participate in training courses, with costs covered by the company, to enhance their understanding of corporate governance responsibilities[174]. - The chairman and co-CEO's dual role is deemed in the best interest of the group, with all major decisions made after consulting the entire board[179]. - The company has established three committees under the board: audit committee, remuneration committee, and nomination committee, to oversee specific aspects of the company's affairs[180]. - The audit committee's responsibilities include monitoring the integrity of financial statements and reviewing risk management and internal control systems[183]. - The company held one annual general meeting and one special general meeting during the year, with full attendance from all directors[178]. - The Compensation Committee held 3 meetings during the year to review and approve the remuneration proposals for directors and senior management[190]. - Attendance records for the Compensation Committee meetings show that all directors attended all 3 meetings[191]. - The Nomination Committee was established on July 20, 2016, and includes two independent non-executive directors and one executive director[192]. - The Nomination Committee held 2 meetings during the year to evaluate the board's structure, size, and composition[196]. - Attendance records for the Nomination Committee meetings indicate full attendance by all directors[197]. - The Nomination Committee's responsibilities include reviewing and approving compensation arrangements for directors dismissed for misconduct[193]. - The Nomination Committee assesses the independence of independent non-executive directors[194]. - The company emphasizes the importance of diversity in the board's composition, considering various factors such as gender and professional background[199]. - The company aims to ensure that candidates possess relevant skills, knowledge, and experience related to its business[199]. - The Nomination Committee follows a structured process for nominating candidates for board appointments or shareholder elections[198].